Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine (Q33948577)

30 July 2017

Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine (English)

1 reference

30 July 2017

1 reference

1 reference

E Bonanni

1

1 reference

30 July 2017

R Galli

2

1 reference

30 July 2017

S Gori

3

1 reference

30 July 2017

L Pasquali

4

1 reference

30 July 2017

M Maestri

5

1 reference

30 July 2017

A Iudice

6

1 reference

30 July 2017

L Murri

7

1 reference

30 July 2017

1 June 2001

1 reference

30 July 2017

Clinical Neurophysiology

1 reference

30 July 2017

112

1 reference

30 July 2017

6

1 reference

30 July 2017

1018-1022

1 reference

A quantitative study of daytime sleepiness induced by carbamazepine and add-on vigabatrin in epileptic patients

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Daytime sleepiness: quantification of a behavioral state

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Adverse reactions to antiepileptic drugs: a multicenter survey of clinical practice. Collaborative Group for Epidemiology of Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Multiple sleep latency tests in epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Nocturnal sleep and daytime somnolence in untreated patients with temporal lobe epilepsy: changes after treatment with controlled-release carbamazepine.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Quantification of Sleepiness: A New Approach

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Safety of long-term lamotrigine in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Daytime sleepiness in epileptic patients on long-term monotherapy: MSLT, clinical and psychometric assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

A multiparametric investigation of daytime sleepiness and psychomotor functions in epileptic patients treated with phenobarbital and sodium valproate: a comparative controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Safety review of adult clinical trial experience with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Daytime sleep tendency before and after discontinuation of antiepileptic drugs in preadolescent children with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Application of the multiple sleep latency test in disorders of excessive sleepiness

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Lamotrigine associated with insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

A survey comparing lamotrigine and vigabatrin in everyday clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

Removal of sedative-hypnotic antiepileptic drugs from the regimens of patients with intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900537-5

7 January 2021

10.1016/S1388-2457(01)00537-5

Identifiers

DOI

1 reference

30 July 2017

1 reference